Ares Management Corporation (NYSE: ARES) in its offering of $500 million of 6.375% senior notes.
Ares Management Corporation (NYSE: ARES) in its $100 million investment in Vinci Partners (NASDAQ: VINP), an alternative investment platform.
InflaRx, a clinical-stage biopharmaceutical company, in:
- its $46 million underwritten public offering of ordinary shares following FDA emergency use authorization for its drug Gohibic (vilobelimab) for the treatment of critically ill, hospitalized COVID-19 patients.
- the amendment of its co-development agreement with Staidson BioPharmaceuticals to support Staidson in its regulatory approval efforts for its proprietary drug candidate in China and concurrent $2.5 million PIPE investment from Staidson.
Clearlake Capital Group in a $400 million senior notes offering to finance its acquisition of Intertape Polymer Group, a manufacturer of paper and film based pressure-sensitive and water-activated tapes, stretch and shrink films, protective packaging, woven and non-woven products and packaging machinery for industrial and retail use.
